Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Glucose Control in Patients With Type 1 Diabetes Under Free-living Conditions With the Insulet Automated Glucose Control System: IDE3

NCT03216460 is registered in ClinicalTrials.gov with Insulet Corporation as lead sponsor.

NCT NCT03216460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03216460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Glucose Control in Patients With Type 1 Diabetes Under Free-living Conditions With the Insulet Automated Glucose Control System: IDE3
Lead sponsor
Insulet Corporation
Phase
Not applicable
Overall status
Completed
Start date
February 4, 2019
Completion date
May 28, 2019
Enrollment
120 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

type1 diabetes mellitus